NEUP fundamentals
An in-depth look to Neuphoria Therapeutics Inc. operating, investing, and financing activities
NEUP free cash flow for Q1 25 is -4.47 M USD. For 2024, NEUP free cash flow was -9.62 M USD and operating cash flow was -9.62 M USD.
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '25
TTM